David A Schwartz, MD
Vanderbilt University Medical Center
Nashville, TN

David A. Schwartz, MD is a Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at Vanderbilt University in Nashville, Tennessee. He founded and currently serves as the Director of the Inflammatory Bowel Disease Center at Vanderbilt University Medical Center. He received his postgraduate training at the Mayo Clinic in Rochester, Minnesota, where he completed a fellowship in Gastroenterology and Hepatology, and advanced training in Inflammatory Bowel Disease and Endoscopic Ultrasound. He is a Fellow of the American College of Gastroenterology and the American Gastroenterological Association. His research has focused on clinical trials for inflammatory bowel disease, imaging of inflammatory bowel disease, the multidisciplinary care of the IBD patient, and the treatment of perianal Crohn’s disease. He has lectured extensively throughout the United States and has written more than 200 articles, book chapters, and abstracts.

The goals of the Gastroenterology Division are to provide outstanding medical care to persons with diseases of the gastrointestinal tract and liver, to train gastroenterology and to perform cutting-edge biomedical research to improve our understanding of digestive diseases. We have 40 full time faculty in the division including research and clinical faculty. There are three strong goals that define the GI Division. The first component is a strong biomedical research with faculty that is focused on innovative discovery-based research. The second is the education and training of medical students, residents, postdoctoral fellows, GI research and GI Clinical fellows. Third the clinical and endoscopic practice at Vanderbilt is focused on compassionate and outstanding patient care. Vanderbilt University Medical Center (VUMC) and the Nashville Veterans Affairs Medical Center (VAMC) both maintain endoscopic units as well as GI clinic facilities. Both a high risk obesity clinic and a malnutrition clinic are housed in the Vanderbilt Center for Human Nutrition. Physicians in the GI Division also provide patient care in the multidisciplinary GERD clinic as well as in the IBD Clinic and the Motility Clinic. Inpatient and outpatient services in GI are provided for VUMC and VAMC separately. The Liver Service covers both hospitals and participates in the VUMC liver transplant program. The Division of Gastroenterology seeks a balance in its clinical and research activities. Our Web Site presents our faculty and their activities in more detail and will provide you with a comprehensive and detailed picture of our activities and interests.

 Colombel, JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF. Adalimumab for the Treatment of Fistulas in Patients With Crohn’s Disease. GUT 2009 Jul;58(7):940-8.

 Rosen MJ, Moulton DE, Koyama T, Morgan WM 3rd, Morrow SE, Herline AJ, Muldoon RL, Wise PE, Polk DB, Schwartz DA. Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease. Inflammatory Bowel Disease 2010 Mar;16(3): 461-468.

 Williams CS, Burch A, Chaturvedi R, McDonough EM, Washington MK, Williams AD, Schwartz DA, Coburn LA, Allaman MM, Steapleton MA, Peek RM, Wilson KT, Hiebert SW. MTG16 Contributes to Epithelial Integrity in Response to Injury MTG16 protects from colonic injury . Gut 2013;62:1446-55.

 Horst S, Chao A, Rosen M, Nohl A, Duley C, Wagnon J, Beaulieu DB, Taylor W, Gaines L, Schwartz DA. Immunosupressive therapy may improve depressive symptoms in patients with Inflammatory Bowel Disease. Digestive Disease and Sciences. 2015;60:465.

 Sandborn, WJ, Lee SD, Randal CW, Gutierrez A, Schwartz DA, Ambarkhane S, Kayhan C, Pierre-Louis B, Schreiber S, Lichtenstein G. Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study. Aliment Pharmacol Ther. 2014 Oct;40(8):903-16.

 Gaines L, Slaughter C, Horst S, Schwartz DA, Wang L, Haman K, Martin C, Kappelman M, Long M, Sandler R. Association between affective-cognitive symptoms of depression and exacerbation of Crohn’s Disease. Am J Gastro 2016

 Cross RK, Jambaulikar G, Langenberg P, Tracy JK, Collins JF, Katz J, Regueiro M, Schwartz DA, Quinn CC. TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial. Contemp Clin Trials. 2015 May;42:132-44. Epub 2015 Mar 24.

 Wiese D, Beaulieu D, Slaughter C, Horst S, Wagnon J, Duley C, Annis K, Nohl A, Herline A, Muldoon R, Geiger T, Wise P, Schwartz DA. A Randomized Prospective Trial of Endoscopic Ultrasound (EUS) to Guide Treatment with Adalimumab (ADA) for Crohn’s Perianal Fistulas. Inflammatory Bowel Dis 2015 2015 Jul;21(7):1594-9. PMID:25985245

 Sandborn, WJ, Melmed GY, McGovern DP, Loftus EV, Choi JH, Abraham B, Lichtenstein G, Lee SD, Randal CW, Schwartz DA, Regueiro M, Siegel CA, Spearman M, Kosutic G, Pierre-Louis B, Coarse J, Schreiber S. Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study. Aliment Pharm Ther 2015 Aug;42(3):330-42

 Gonzalez RS, Schwartz DA, Shi C. Colestipol granules in the colon: macroscopic and microscopic findings. Histopathology. 2015 Jul;67(1):141-2. doi: 10.1111/his.12618. Epub 2015 Jan 13.

 Harris KA, Horst S, Gadani A, Nohl A, Annis K, Duley C, Beaulieu D, Ghazi L, Schwartz DA. “Patients with refractory Crohn’s disease successfully treated with Ustekinumab”. IBD Journal Merkley S, Horst S, Beaulieu D, Duley C, Annis K, Nohl A, Schwartz DA. The “Use of IVIG in IBD patients with contraindications or who are unresponsive to conventional therapy for Inflammatory Bowel Disease”. IBD Journal 2015 Aug;21(8):1854-9 PMID:25993689

Content available soon!

    Webcasts

    Mechanistic Approaches to IBD: Current & Future Management Strategies

    Stephen B. Hanauer, MD (chair), Gary R. Lichtenstein, MD, David G. Binion, MD, William Sandborn, MD, Corey A. Siegel, MD

    Didactic Lecture

    view details >

    Precision Medicine & Novel Therapeutics

    Maria T. Abreu, MD, David G. Binion, MD, Stephen B. Hanauer, MD, Gary R. Lichtenstein, MD, Eduardo V. Loftus JR., MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2015: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Update on IBD

    Raymond Cross, MD

    Didactic Lecture

    view details >

    Non-Digestive Neoplasms in IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Optimizing Therapies for Severe Ulcerative Colitis

    Ellen Scherl, MD

    Didactic Lecture

    view details >

    Epidemiology of IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Gi Summit 2014

    Stephen Hanauer, MD and Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2014: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Amar Deshpande, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW - Reporting on IBD

    Maria T. Abreu, MD, Stephen B. Hanauer, MD, Scot Plevy, MD

    Didactic Lecture

    view details >

    eMonograph

    Expert Perspectives in the Management of Inflammatory Bowel Disease (IBD): A Review of Recent Advances

    view details >

    Advances in IBD

    view details >

    Optimizing the Management of Inflammatory Bowel Disease

    view details >

    Update in the Medical Management of Ulcerative Colitis: 2011

    view details >

    Webcasts

    Mechanistic Approaches to IBD: Current & Future Management Strategies

    Stephen B. Hanauer, MD (chair), Gary R. Lichtenstein, MD, David G. Binion, MD, William Sandborn, MD, Corey A. Siegel, MD

    Didactic Lecture

    view details >

    Precision Medicine & Novel Therapeutics

    Maria T. Abreu, MD, David G. Binion, MD, Stephen B. Hanauer, MD, Gary R. Lichtenstein, MD, Eduardo V. Loftus JR., MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2015: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Update on IBD

    Raymond Cross, MD

    Didactic Lecture

    view details >

    Non-Digestive Neoplasms in IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Optimizing Therapies for Severe Ulcerative Colitis

    Ellen Scherl, MD

    Didactic Lecture

    view details >

    Epidemiology of IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Gi Summit 2014

    Stephen Hanauer, MD and Philip Schoenfeld, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2014: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Amar Deshpande, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW - Reporting on IBD

    Maria T. Abreu, MD, Stephen B. Hanauer, MD, Scot Plevy, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2017 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.